Explore the categories so you can find more about your search.
Categorie > Colorectal Cancer
Healthcare Providers Play Role In Likelihood Of Colorectal Cancer Screening
Categorie : Colorectal CancerA new study published in Cancer reports that thelikelihoodof patients' obtaining colorectal cancer screenings is dependent onhealth care providers. Dr. Melissa M. Farmer of Veterans Affairs andcolleagues suggest that interventions targeting both the provider andthepatient are needed to boost colorec ...
read more 
Fri Feb 2008
U.S. Cancer Deaths Down But Far Too Few Americans Screened For Colon Cancer
Categorie : Colorectal CancerNew data revealing decreasing trends in cancer deaths in the United States overall, and in colorectal cancer deaths in particular, highlight the remarkable benefits of colorectal cancer screening tests, but the lifesaving potential of these tests is unrealized for many Americans, according to expert ...
read more Fri Feb 2008
Inclusion Of Six-Year Overall Survival Data In The Eloxatin(R) (oxaliplatin Injection) Prescribing Information Granted FDA Priority Review
Categorie : Colorectal CancerSanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and assigned priority review status to a supplemental new drug application (sNDA) that proposes changes to the Eloxatin(R) (oxaliplatin injection) prescribing information (PI) to include a six-year ana ...
read more Fri Feb 2008
The Facts African Americans Need To Know About Colon Cancer
Categorie : Colorectal CancerEach year more than 150,000 people in the United States are diagnosed with colon cancer and over 50,000 will die from the disease. Death rates from colon cancer are higher among African Americans than any other population group in the U.S. The American Society for Gastrointestinal Endoscopy (ASGE ...
read more Fri Feb 2008
EU Grants Broad Approval Of Xeloda For Patients With Metastatic Colorectal Cancer - Oral Chemotherapy That Significantly Reduces Treatment Time
Categorie : Colorectal CancerRoche announced that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic colorectal cancer in combination with any chemotherapy in all lines of treatment with or without Avastin. This broad approval means that more patients suffering from ...
read more Tue Feb 2008
Risk Of Colorectal Polyps May Be Doubled By Smoking
Categorie : Colorectal CancerSmokers have a two-fold increased risk of developing colorectal polyps, the suspected underlying cause of most colorectal cancers (CRC), according to a study published in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.The results from this meta ...
read more Tue Feb 2008
Use Of Colorectal Cancer Screening Affected By Provider Influence And Patient Barriers
Categorie : Colorectal CancerA new study shows that health care providers play a key role in the likelihood their patients are screened for colorectal cancer. The findings suggest that interventions targeting both the provider and the patient are needed to boost colorectal cancer screening rates, and in particular must take int ...
read more Tue Feb 2008
Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX(R)
Categorie : Colorectal CancerCancer research pioneer Michael G. Hanna Jr. Ph.D., also Vaccinogen, Inc.'s Founder, Chairman and CEO has acquired the rights to OncoVAX(R), a vaccine with the potential to prevent colon cancer from recurring in many patients. "This agreement represents a major step forward in defeating cancer b ...
read more Tue Feb 2008
Largest 2009 Grant From NHMRC Awarded To Ludwig Institute For Cancer Research
Categorie : Colorectal CancerAustralia's National Health & Medical Research Council (NHMRC) has awarded its largest grant for 2009 to the Ludwig Institute for Cancer Research (LICR) in Melbourne.This grant will allow the LICR to bring together 18 key investigators from five Melbourne institutions to develop new ways of detectin ...
read more Tue Feb 2008
Wild-type KRAS Colorectal Tumours Respond To Panitumumab
Categorie : Colorectal CancerPatients with colorectal tumours expressing the wild-type KRAS gene show significantly increased progression free survival with panitumumab (Vectibix), a monoclonal antibody targeting EGFR, while those with mutations in KRAS do not, according to data from a phase 3 trial reported at the 2008 Gastroi ...
read more Sun Feb 2008
Colon Cancer Gene Reveals New Function
Categorie : Colorectal CancerDartmouth Medical School geneticists have discovered a striking turnabout role for a gatekeeper known to put on the brakes for colon cancer. Flaws in a gene called adenomatous polyposis coli (APC), which normally prevents excessive cell growth, are thought to trigger development of most colorectal c ...
read more Thu Jan 2008
Vectibix(R) (Panitumumab) Now Available For The Treatment Of Advanced Colorectal Cancer In The UK
Categorie : Colorectal CancerAmgen UK announced an important milestone in treating people with metastatic colorectal cancer. Vectibix® (panitumumab), licensed by the European Commission in December 2007, is now available in the United Kingdom. Vectibix is indicated as monotherapy for the treatment of patients with epidermal g ...
read more Thu Jan 2008
Surgeons Remove Large Tumor, Transplant Bowel Back Into Patient
Categorie : Colorectal CancerSurgeons at the University of Illinois Medical Center at Chicago removed an 11-pound desmoid tumor from the abdominal cavity of an Arkansas man and performed a transplant using a segment of his own small intestine rescued during surgery, preserving his ability to eat and digest food. "The tumor h ...
read more Thu Jan 2008
Genomic Health Announces Identification Of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
Categorie : Colorectal CancerGenomic Health, Inc. (Nasdaq: GHDX) announced the results of studies that have identified genes that could help predict the likelihood of recurrence and chemotherapy benefit for early-stage (stage II and III) colon cancer. The company is conducting detailed analyses of these studies to select a fina ...
read more Thu Jan 2008
Studies Demonstrate Increased Efficacy Of Erbitux In Metastatic Colorectal Cancer Patients With KRAS Wild-type Tumors
Categorie : Colorectal CancerFindings from three studies demonstrate the increased efficacy of Erbitux® (cetuximab) in patients with metastatic colorectal cancer (mCRC) who have a wild-type KRAS tumor, highlighting the potential role of KRAS as a predictive biomarker in the treatment of this common cancer. ...
read more Thu Jan 2008
Inflammation-Induced Colon Cancer Stopped In Its Tracks By TNF-Alpha Antagonist
Categorie : Colorectal CancerIndividuals with the inflammatory bowel disease ulcerative colitis are at increased risk of developing colon cancer. New data generated by Naofumi Mukaida and colleagues at Kanazawa University, Japan, identified a central role for the soluble factor TNF-alpha in the development of colon cancer in mi ...
read more Thu Jan 2008
Advances In The Treatment Of Gastrointestinal Cancers
Categorie : Colorectal CancerNew research on the treatment of gastrointestinal cancers is being presented at the 5th annual Gastrointestinal Cancers Symposium, being held January 25-27 at the Orlando World Center Marriott. The presscast highlighting noteworthy studies can be accessed here. ...
read more Thu Jan 2008
KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy And Patient Reported Outcomes In Advanced Colorectal Cancer Patients
Categorie : Colorectal CancerAmgen (NASDAQ: AMGN) announced the results of a biomarker analysis which indicated that in metastatic colorectal cancer (mCRC) patients who have failed all other chemotherapeutic regimens, the efficacy of Vectibix(TM) (panitumumab) monotherapy is confined to patients with non-mutated (wild-type) KRA ...
read more Thu Jan 2008
Radiation Before Extensive Surgery For Rectal Cancer Reduces Risk Of Cancer Coming Back, But Has Little Impact On Survival
Categorie : Colorectal CancerA short, intense course of radiotherapy given before extensive surgery for rectal cancer does not significantly improve overall survival for patients with this tumour type, despite decreasing the likelihood of the cancer reemerging in the same place, according to the long-term results of a randomise ...
read more Tue Jan 2008
50 Percent Of Americans Age 50 And Older Have Never Had A Colonoscopy
Categorie : Colorectal CancerOnly half of all Americans age 50 and over have had a colonoscopy, one of several common screening tests for colon cancer, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The U.S. Preventive Services Task Force recommends that all people age 50 and over ...
read more Tue Jan 2008
Custom Search
